INREBIC

Identification of Inrebic

No description

Google image searchProduct monograph

Active ingredient

fedratinib (fedratinib hydrochloride), 100 MG

DIN: 02502445

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 23-NOV-2023

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EJ — Janus-associated kinase (JAK) inhibitors (ATC, ATC/DDD)
• L01EJ02 — FEDRATINIB (ATC/DDD)

Reference brand drug: Inrebic

External Links for Inrebic

Search on Google

• Inrebic side effects
• Inrebic dosage
• fedratinib side effects
• fedratinib dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find inrebic photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.